Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

Record identifier

TN_cdi_proquest_journals_2446966114

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2446966114

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

Full title

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2020, Vol.21 (10), p.1353-1365

Record Identifier

TN_cdi_proquest_journals_2446966114

Language

English

Formats

Publication information

Publisher

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_proquest_journals_2446966114

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2446966114

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card